Literature DB >> 33386806

Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.

Christopher Gonzalez1,2,3, Nicole S Tommasi1,2, Danielle Briggs1,2,3, Michael J Properzi3, Rebecca E Amariglio1,2,3, Gad A Marshall1,2,3.   

Abstract

BACKGROUND: Financial capacity is often one of the first instrumental activities of daily living to be affected in cognitively normal (CN) older adults who later progress to amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia.
OBJECTIVE: The objective of this study was to investigate the association between financial capacity and regional cerebral tau.
METHODS: Cross-sectional financial capacity was assessed using the Financial Capacity Instrument -Short Form (FCI-SF) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Linear regression models with backward elimination were used with FCI-SF total score as the dependent variable and regional tau and tau-amyloid interaction as predictors of interest in separate analyses. Education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B were used as covariates.
RESULTS: Significant associations were found between FCI-SF and tau regions (entorhinal: p < 0.001; inferior temporal: p < 0.001; dorsolateral prefrontal: p = 0.01; posterior cingulate: p = 0.03; precuneus: p < 0.001; and supramarginal gyrus: p = 0.005) across all participants. For the tau-amyloid interaction, significant associations were found in four regions (amyloid and dorsolateral prefrontal tau interaction: p = 0.005; amyloid and posterior cingulate tau interaction: p = 0.005; amyloid and precuneus tau interaction: p < 0.001; and amyloid and supramarginal tau interaction: p = 0.002).
CONCLUSION: Greater regional tau burden was modestly associated with financial capacity impairment in early-stage AD. Extending this work with longitudinal analyses will further illustrate the utility of such assessments in detecting clinically meaningful decline, which may aid clinical trials of early-stage AD.

Entities:  

Keywords:  Alzheimer’s disease; amyloid; financial capacity; instrumental activities of daily living; mild cognitive impairment; positron emission tomography; tau

Year:  2021        PMID: 33386806      PMCID: PMC7870560          DOI: 10.3233/JAD-201122

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  35 in total

1.  Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.

Authors:  Gad A Marshall; Natacha Lorius; Joseph J Locascio; Bradley T Hyman; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.

Authors:  Duygu Tosun; Susan Landau; Paul S Aisen; Ronald C Petersen; Mark Mintun; William Jagust; Michael W Weiner
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

3.  Cerebral metabolic correlates of four dementia scales in Alzheimer's disease.

Authors:  E Salmon; S Lespagnard; P Marique; F Peeters; K Herholz; D Perani; V Holthoff; E Kalbe; D Anchisi; S Adam; F Collette; G Garraux
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study.

Authors:  Virginie Dauphinot; Floriane Delphin-Combe; Christelle Mouchoux; Aline Dorey; Anthony Bathsavanis; Zaza Makaroff; Isabelle Rouch; Pierre Krolak-Salmon
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?

Authors:  Gad A Marshall; Rebecca E Amariglio; Reisa A Sperling; Dorene M Rentz
Journal:  Neurodegener Dis Manag       Date:  2012-10-01

6.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

7.  Characterizing multiple memory deficits and their relation to everyday functioning in individuals with mild cognitive impairment.

Authors:  Maureen Schmitter-Edgecombe; Ellen Woo; David R Greeley
Journal:  Neuropsychology       Date:  2009-03       Impact factor: 3.295

Review 8.  The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer's Disease-Review of Literature and Interesting Images.

Authors:  Subapriya Suppiah; Mellanie-Anne Didier; Sobhan Vinjamuri
Journal:  Diagnostics (Basel)       Date:  2019-06-25

9.  Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.

Authors:  Omar A Halawa; Jennifer R Gatchel; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Gad A Marshall
Journal:  Alzheimers Res Ther       Date:  2019-01-31       Impact factor: 6.982

10.  Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease.

Authors:  Nicolai Franzmeier; Julia Neitzel; Anna Rubinski; Ruben Smith; Olof Strandberg; Rik Ossenkoppele; Oskar Hansson; Michael Ewers
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.